KC, M., MA, M., SW, M., ET, V. M., M, K., & TH, K. (2022). Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin. Clinical pharmacokinetics, 61(3), 363. https://doi.org/10.1007/s40262-021-01088-w
Chicago Style (17th ed.) CitationKC, Molina, Miller MA, Mueller SW, Van Matre ET, Krsak M, and Kiser TH. "Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin." Clinical Pharmacokinetics 61, no. 3 (2022): 363. https://doi.org/10.1007/s40262-021-01088-w.
MLA (9th ed.) CitationKC, Molina, et al. "Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin." Clinical Pharmacokinetics, vol. 61, no. 3, 2022, p. 363, https://doi.org/10.1007/s40262-021-01088-w.
Warning: These citations may not always be 100% accurate.